Amicus Therapeutics (NASDAQ:FOLD) has been downgraded to Hold by StockNews.com.
Research analysts from StockNews.com lowered their recommendation for Amicus Therapeutics (NASDAQ: FOLD), shifting it from a "buy" rating to a ...
Tag: FOLD, Analyst Rating
Amicus Therapeutics, Inc. receives a $273,000 investment from Pearl River Capital LLC.
The most recent Form 13F report that Pearl River Capital LLC submitted to the Securities and Exchange Commission revealed that ...
Cubist Systematic Strategies LLC acquires 70,296 Amicus Therapeutics, Inc. shares (NASDAQ:FOLD)
The most recent Form 13F filing that Cubist Systematic Strategies L.L.C.Made with the Securities and Exchange Commission revealed that during ...
Boothbay Fund Management LLC purchases 13,553 Amicus Therapeutics, Inc. shares (NASDAQ:FOLD)
Boothbay Fund Management L.L.C. grew its holdings in Amicus Therapeutics, INC (NASDAQ: FOLD) during the company's third fiscal quarter, as ...
On Wednesday, Amicus Therapeutics (FOLD) will report its quarterly earnings.
Amicus Therapeutics (NASDAQ: FOLD) will release its quarterly results report for the preceding quarter on March 1, before the stock ...
Mutual of America Capital Management LLC Increases Its Position in Amicus Therapeutics, Inc. (NASDAQ:FOLD)
The most recent filing with the S.E.C.S.E.C. reveals that during the third quarter, Mutual of America Capital Management L.L.C.L.L.C.Increased the ...
Prudential Financial Inc. owns $1.83 million in Amicus Therapeutics, Inc. (NASDAQ:FOLD)
The most recent Form 13F filing that Prudential Financial INC submitted to the Securities and Exchange Commission revealed that during ...
Victory Capital Management Inc. has purchased shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD).
According to the most recent report that Victory Capital Management INC submitted to the Securities and Exchange Commission, the amount ...
Amicus Therapeutics, Inc. receives a $132,000 investment from Fox Run Management L.L.C. (NASDAQ:FOLD)
According to the most recent filing that Amicus Therapeutics, Inc.Made with the Securities and Exchange Commission, Fox Run Management L.L.C.Purchased ...
Barclays PLC increased its holdings in Amicus Therapeutics, Inc. (NASDAQ:FOLD).
According to the most recent filing that Barclays PLC made with the Securities and Exchange Commission, during the third quarter ...